Read the full report to learn what this exciting advance could mean for your business: GLP1 and other incretin-based therapies arent just changing medicine theyre changing how we think about risk in life & health underwriting
They work through entirely different mechanisms and have very different risk profiles
But also: there was an overall reduced risk of heart failure, and evidence that the kidneys were protected as well
Providers increasingly encounter patients Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,783 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment
The point is, you are pregnant